Search results

The National Deuteration Facility offers access to deuterated molecules prepared by both in vivo biodeuteration and chemical deuteration techniques.

Learn. Create. Innovate

A large team of ANSTO scientists in collaboration with University of Wollongong researchers has developed a new hybrid technique that enhances the effectiveness of a cutting-edge form of radiation therapy for advanced cancer.

You are invited to submit to the various awards from ANSTO, User Advisory Committee (UAC) and Australian Neutron Beam User Group (ANBUG). 

Australia’s Open Pool Australian Lightwater (OPAL) reactor is a state-of-the-art 20 megawatt multi-purpose reactor that uses low enriched uranium (LEU) fuel to achieve a range of  activities to benefit human health, enable research to support a more sustainable environment and provide innovative solutions for industry.

ANSTO is home to over AUD$1.3B state of the art instruments and science technology. To access ANSTO’s world-leading and highly specialised facilities and capabilities, please contact our Industry Engagement team. This way we can co-ordinate your enquiry and provide advice on your application.

ANSTO offers a broad range of programs and services to various industries and customers. Many of these services, including the Australian Nuclear Medicine Traceability program, are supported by online customer portals.

The OPAL research reactor's design and integrated safety features mean it is extremely safe; a fact confirmed by independent analysis.